Metabolic associated fatty liver disease in patients with type 2 diabetes mellitus
Journal: Meditsinskiy sovet = Medical Council
Year: 2026

Introduction. In patients with type 2 diabetes mellitus (T2DM) and obesity, the incidence of metabolically associated fatty liver disease (MAFLD) varies from 70 to 100%, and cardiovascular diseases are five times more common. Metabolic risk factors (RF) for fatty liver disease associated with T2DM are a dangerous combination, mutually aggravate each other’s course and escalate the number of adverse outcomes. Aim. To investigate the frequency of metabolic risk factors in fatty liver disease in pa